Regulatory Affairs Managers face a formidable “Paperwork Wall” when seeking global market access for medical devices. Each country enforces unique compliance marks, regulations, and in-country testing requirements. Devices must satisfy standards for safety, conformity, and approval, while gma compliance and international product certification demand accredited test reports and clear documentation. Achieving uk market access or other registration often hinges on precise compliance assessment, country-specific regulatory interpretation, and adherence to harmonized standards. Strategic certification applications and attention to National Deviations streamline regulatory approval for devices, ensuring efficient compliance.
Principais conclusões
Understand the CB Scheme as a strategic tool for global market access. It simplifies the certification process for medical devices across multiple countries.
Include National Deviations in the initial test plan. This prevents costly re-testing and delays in market entry for medical devices.
Follow the CE marking process to ensure compliance with EU regulations. This involves thorough testing and documentation to meet safety and performance standards.
Prepare separate UKCA documentation post-Brexit. Ensure that devices meet UK-specific requirements alongside CE marking to avoid compliance issues.
Recognize the difference between FDA and NRTL marks. The power supply unit must achieve an NRTL mark to support the medical device’s FDA submission.
Adhere to DoE Level VI energy efficiency requirements for medical devices in the US. This compliance is crucial for successful market entry.
Plan for Japan’s strict PSE Diamond Mark requirements. Ensure all safety and EMI standards are met to avoid duplicate testing.
Utilize DILITHINK’s comprehensive CB Report for streamlined certification. This report covers over 50 countries, reducing time and costs associated with compliance.
The Core Strategy: The CB Scheme (IECEE) “Passport”
How It Works
The CB Scheme (IECEE) serves as a strategic Market Access Strategy for dispositivos médicos. Regulatory Affairs Managers rely on this system to streamline global market access. The CB Test Report, based on IEC 60601-1 Ed. 3.2, acts as a “Master Key” for international conformity. Accredited test reports from a certified laboratory confirm that devices meet harmonized standards for safety and performance. Once a manufacturer obtains this report, they can convert it into national certificates for different countries.
However, the process does not follow a universal path. Each country enforces its own regulations and requirements for approval. Manufacturers must verify approvals for every target market, which increases the complexity of compliance assessment. This approach often leads to elaborate and time-consuming testing procedures. High costs can result from the need to address each country’s unique standards and documentation. Regulatory teams must plan for these challenges early in the certification process to avoid delays in registration.
Dica: The CB Test Report is not a final certificate. It is a foundation that supports the conversion to national marks, such as CE, UKCA, PSE, or CCC, depending on the destination market.
The Critical Step: National Deviations
The “Gotcha”: You MUST include deviations (US, JP, UK, AU) in the initial test plan. If you forget, you pay for re-testing later.
National Deviations represent the most critical aspect of the CB Scheme. These deviations reflect country-specific requirements, such as US voltages, UK plugs, or Japanese EMI limits. Regulatory Affairs Managers must ensure that all relevant National Differences are included and tested during the initial CB testing phase. This step determines whether devices can achieve compliance and approval in multiple markets without costly re-testing.
The most common and expensive mistake involves overlooking National Deviations at the start. Project managers who neglect to specify these differences face duplicate testing, increased costs, and delayed market entry. For example, a device tested only to the base IEC standard may fail to meet US or UK requirements for safety or conformity. This oversight can force a return to the laboratory for additional testing, which disrupts the certification timeline and increases expenses.
A strategic approach involves mapping out all target markets and their National Deviations before submitting devices for CB testing. This ensures that the CB Test Report covers every necessary requirement for global market access. Regulatory teams should coordinate with accredited laboratories to confirm that all deviations are addressed in the initial test plan.
Checklist for Success:
Identify all target countries for registration.
List National Deviations for each market (e.g., US, JP, UK, AU).
Confirm inclusion of these deviations in the initial CB test plan.
Review harmonized standards and local regulations for updates.
Maintain complete documentation for each device.
By prioritizing National Deviations, manufacturers can avoid the pitfalls of duplicate testing and accelerate the approval process for medical devices. This proactive strategy supports efficient compliance, reduces costs, and ensures timely market entry.
Europe & UK: Navigating the Post-Brexit Split
The CE Mark (EU MDR)
Compliance with Regulation (EU) 2017/745. The focus on “General Safety and Performance Requirements” (GSPR).
Regulatory Affairs Managers recognize the CE mark as a cornerstone for global market access in Europe. Medical devices must comply with Regulation (EU) 2017/745, which sets strict General Safety and Performance Requirements (GSPR). The CE marking process ensures that devices meet essential health, safety, and environmental protection standards before entering the European market.
Manufacturers must follow a structured Market Access Strategy. They begin by identifying applicable harmonized standards, which provide a presumption of conformity. The process may require third-party assessment by a Notified Body, especially for higher-risk devices. Comprehensive compliance assessment involves rigorous testing and verification to confirm that the product meets all requirements.
A technical file forms the backbone of documentation. This file includes design details, manufacturing processes, and test reports. After confirming conformity, manufacturers issue declarations of conformity, which allow them to affix the CE mark to their devices. A tabela seguinte resume the main steps for CE marking under Regulation (EU) 2017/745:
Requisito | Descrição |
|---|---|
Identify applicable harmonized European Norms (hENs) | Determine which hENs apply to the product for presumption of conformity. |
Determine if third-party assessment is needed | Assess if a Notified Body must review the device, based on risk classification. |
Assess product conformity | Conduct thorough testing and verification to ensure compliance with essential safety and environmental standards. |
Compile a technical file | Prepare comprehensive documentation, including design, manufacturing, and test reports. |
Make a declaration of conformity | Complete and sign the Declaration of Conformity before affixing the CE mark. |
CE marking provides a unified approach to approval and registration across the European Economic Area. It streamlines compliance and supports efficient market entry for medical devices.
The UKCA Headache
Explain the UK’s separation. Power supplies now need a separate UK Declaration of Conformity and UK Importer details on the label. How to manage dual CE/UKCA marking.
Brexit introduced new challenges for regulatory teams. The UKCA mark now serves as the required conformity mark for medical devices in Great Britain. Devices must meet UK-specific regulations, which mirror many EU requirements but require separate certification and documentation.
Manufacturers must prepare a UK Declaration of Conformity, distinct from the EU version. The UK Importer labeling requirement stands as a critical compliance point. Every device must display the UK Importer’s name and address on the label, ensuring traceability and accountability for market surveillance.
Managing dual CE/UKCA marking demands a strategic approach. Many companies align their technical files and testing to cover both sets of requirements, leveraging harmonized standards and National Deviations identified during the initial CB Scheme process. This strategy minimizes duplicate testing and streamlines approval for both markets.
Dica: Regulatory Affairs Managers should maintain up-to-date documentation for both CE and UKCA marking. Coordinating with local partners and importers ensures smooth registration and ongoing compliance.
Dual marking supports efficient global market access and reduces delays in product launch. By addressing both CE and UKCA requirements from the outset, manufacturers avoid costly rework and ensure continuous approval for their medical devices.
North America: Distinguishing FDA from Safety Marks
FDA 510(k) vs. NRTL
Clarification: The PSU itself usually gets an NRTL Mark (UL, ETL, TUV) to AAMI ES60601-1, supporting the medical device’s FDA submission. It does not get its own 510(k).
Regulatory Affairs Managers often encounter confusion when preparing medical devices for global market access in North America. The United States enforces strict regulations for medical devices, but the power supply unit (PSU) follows a different path. The FDA does not grant clearance or registration to the PSU itself. Instead, the PSU must achieve an NRTL mark, such as UL, ETL, or TUV, demonstrating compliance with AAMI ES60601-1. This safety approval supports the medical device’s FDA submission and forms a critical part of the Market Access Strategy.
Manufacturers must understand that the NRTL mark serves as evidence of conformity with harmonized standards. The NRTL mark assures regulatory bodies that the PSU meets essential safety requirements. The medical device submission to the FDA references this approval, but the PSU does not receive its own 510(k). This distinction streamlines the certification process and avoids unnecessary duplication.
Nota: Always include the NRTL safety certificate in the device’s technical documentation. This step ensures smooth FDA review and supports the overall compliance strategy.
A typical process for North American market entry includes:
Select a PSU certified to AAMI ES60601-1 by an NRTL.
Integrate the PSU into the medical device design.
Prepare technical documentation, including the NRTL certificate.
Submit the complete package as part of the FDA 510(k) process for the medical device.
This approach aligns with harmonized standards and addresses National Deviations for the US market. It also supports efficient declarations of conformity and registration.
The “DoE Level VI” Efficiency Rule
Don’t forget energy efficiency (CEC/DoE) requirements which are strictly enforced in the US.
In addition to safety, energy efficiency plays a vital role in North American compliance. The Department of Energy (DoE) Level VI rule sets strict requirements for external power supplies. All medical devices with external adapters must meet these standards to achieve ce and ukca marking for the US market.
The DoE Level VI rule covers:
Requisito | Descrição |
|---|---|
No-load power consumption | Limits the amount of power consumed when the device is not in use. |
Active mode efficiency | Sets minimum efficiency levels during normal operation. |
Marking and labeling | Requires clear labeling to demonstrate compliance with DoE standards. |
Manufacturers must verify that their devices meet these requirements before entering the US market. Failure to comply can delay ce marking, ukca marking, and registration. Regulatory teams should include DoE compliance in their initial test plan and technical documentation.
Dica: Always request DoE Level VI test reports from your PSU supplier. This documentation supports ce, ukca, and FDA submissions and ensures a smooth path to global market access.
By addressing both NRTL safety and DoE efficiency requirements, manufacturers can streamline certification, reduce costs, and accelerate time to market for medical devices in North America.
Challenging Asian Markets: Japan (PSE) and China (CCC)
Japan: The PSE Diamond Mark
Japan is strict. Explain the requirement for PSE Diamond (Mandatory) for DC adapters and the unique EMI limits. Mention “Duplicate Testing” requirements.
Japan enforces some of the most rigorous regulations for medical devices entering its market. The PSE Diamond Mark stands as a mandatory requirement for DC adapters used in medical devices. Regulatory Affairs Managers must understand that Japan’s Ministry of Economy, Trade and Industry (METI) demands strict adherence to safety and electromagnetic interference (EMI) standards. These standards often exceed those found in ce or ukca marking processes.
To obtain the PSE Diamond Mark, manufacturers must follow a structured Market Access Strategy. Accredited laboratories must conduct all product tests. The process includes a mandatory factory audit to verify that the production site complies with Japanese safety standards. Regular follow-up audits ensure ongoing compliance. The following table summarizes the core requirements for PSE Diamond Mark certification:
Tipo de requisito | Descrição |
|---|---|
Product Tests | Tests must be conducted in an accredited laboratory. |
Mandatory Factory Audit | An audit of the production site to ensure compliance with safety standards. |
Regular Follow-up Audits | Ongoing audits to ensure continued compliance with the standards. |
Japan also enforces unique EMI limits. Devices must pass these tests before they can achieve registration. Unlike ce or ukca, Japan often requires “Duplicate Testing” of components, even if they have already passed international standards. This approach ensures that all devices meet local requirements without exception.
Dica: Regulatory teams should plan for longer lead times and additional costs when targeting Japan. Early coordination with accredited labs and local partners can help streamline the process.
China: GB 9706.1 Specifics
China’s GB standards often lag slightly behind IEC editions. Highlighting the need to check the exact GB version currently in force.
China presents its own set of challenges for global market access. The China Compulsory Certification (CCC) system applies to many medical devices, and the GB 9706.1 standard forms the foundation for safety compliance. Regulatory Affairs Managers must recognize that China’s GB standards frequently lag behind the latest IEC editions. For example, while ce and ukca marking may reference IEC 60601-1 Ed. 3.2, China may still enforce an earlier version.
Manufacturers must check the exact GB version in force before starting the certification process. Failure to align with the current requirements can delay registration and market entry. Devices must undergo local testing, and all technical documentation must be translated and submitted according to Chinese regulations.
Nota: Always confirm the latest GB standard with your local representative or certification body before preparing your technical file.
A strategic Market Access Strategy for China includes:
Identifying the current GB standard for medical devices.
Preparing harmonized test reports that match Chinese requirements.
Coordinating with local regulatory agencies for smooth registration.
By understanding the unique requirements in Japan and China, Regulatory Affairs Managers can build a robust compliance plan. This approach supports efficient global market access for medical devices and reduces the risk of costly delays.
DILITHINK’s “Global Ready” Certification Package
The “One-Stop” Solution
How DILITHINK provides a comprehensive CB Report covering 50+ countries.
DILITHINK offers a strategic Market Access Strategy for medical devices by delivering a single, comprehensive CB Test Report. This report covers harmonized standards and National Deviations for over 50 countries. Regulatory Affairs Managers can rely on this approach to simplify the path to global market access. DILITHINK’s team works with accredited laboratories to ensure that every device meets the latest edition of IEC 60601-1, including all relevant country-specific requirements.
Manufacturers often face delays and extra costs when they must repeat testing for each market. DILITHINK eliminates this barrier by planning for National Deviations from the start. The CB Report acts as a “Global Passport,” allowing devices to convert seamlessly into local certifications such as CE, UKCA, PSE, and CCC. This process reduces the time and expense associated with duplicate testing and accelerates registration in multiple regions.
DILITHINK’s solution supports regulatory teams by providing a clear, unified path to compliance. This approach ensures that devices meet safety and performance standards everywhere they are sold.
Documentation Support
We provide the full technical file (ISO 13485 certs, EM reports, Schematics) needed for your local registration.
DILITHINK understands that robust documentation forms the foundation of successful registration for medical devices. The company supplies a complete technical file with every adapter, supporting both compliance and regulatory review. This file includes ISO 13485 certificates, electromagnetic compatibility (EM) reports, and detailed schematics. These documents help regulatory teams demonstrate conformity with harmonized standards and streamline the approval process.
The following table summarizes how DILITHINK’s technical file supports international compliance:
Norma de conformidade | Descrição |
|---|---|
ISO 13485 | Ensures quality and regulatory requirements for medical devices. |
Commitment | Exceeds customer expectations while ensuring safety and quality throughout the product lifecycle. |
Regulatory Affairs Managers benefit from having all required documentation in one place. This support reduces the risk of missing information during audits or submissions. DILITHINK’s technical file aligns with the expectations of authorities in Europe, the UK, the US, Japan, China, and other key markets.
Key components of DILITHINK’s technical file:
Certificação ISO 13485
Electromagnetic compatibility test reports
Detailed schematics and component lists
Factory audit records
This comprehensive package gives manufacturers confidence that their devices will meet the demands of global market access. DILITHINK’s commitment to quality and compliance helps regulatory teams achieve faster, smoother registration for medical devices worldwide.
Certification for medical devices resembles a chess game. Regulatory Affairs Managers must plan each move, addressing National Deviations early to ensure smooth market access. Global regulatory changes, such as the European Medical Device Regulation and upcoming FDA requirements, impact devices by altering labeling, documentation, and quality assurance standards.
Regulamentação | Impact on Certification Process |
|---|---|
European Medical Device Regulation (MDR) | Requires compliance affecting product labeling and documentation. |
Upcoming FDA Requirements | Necessitates changes to meet quality assurance standards. |
Device risk classes influence the level of quality assurance:
Class I and IIa devices require baseline code quality checks.
Higher-risk devices demand rigorous standards and continuous monitoring.
Partnering with a PSU vendor who understands harmonized standards and registration requirements worldwide streamlines compliance. Download DILITHINK’s “Global Certification Roadmap for Medical Adapters” to support your market access strategy.
Perguntas frequentes
What is the CB Scheme and why is it important for global market access?
The CB Scheme provides a unified approach for certifying devices. It allows manufacturers to use one test report as a foundation for multiple national certifications. This strategy streamlines the Market Access Strategy and reduces time and costs.
How do National Deviations affect certification for devices?
National Deviations represent country-specific requirements. They must be included in the initial test plan. Missing these differences can lead to duplicate testing and delays. Addressing them early ensures smooth approval for devices in all target markets.
Does the FDA require separate registration for power supplies in medical devices?
The FDA does not register power supplies separately. Instead, devices must show compliance with harmonized standards like AAMI ES60601-1. The NRTL mark supports the overall submission for medical devices.
What is the difference between CE and UKCA marking for devices?
CE marking applies to the European Union. UKCA marking is required for Great Britain. Both marks require separate declarations and importer details. Manufacturers should align their Market Access Strategy to cover both sets of requirements.
Why does Japan require duplicate testing for devices?
Japan enforces strict local standards. Even if devices pass international tests, Japan may require duplicate testing for components. This ensures full compliance with Japanese safety and EMI limits.
How does DILITHINK’s CB Report help with Market Access Strategy?
DILITHINK’s CB Report covers harmonized standards and National Deviations for over 50 countries. This comprehensive approach allows devices to convert quickly into local certifications, supporting efficient global market access.
What documents are needed for local registration of medical devices?
Regulatory teams need a complete technical file. This includes ISO 13485 certificates, electromagnetic compatibility reports, schematics, and factory audit records. Proper documentation supports compliance with harmonized standards and smooth registration.
